Medroxyprogesterone 150 MG/mlml
Ended Awarded
- Contract number
- SPE2DB25FQ2UA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,495
Award facts
- Contract value 100% obligated
- $1,495.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,495.01 to AmerisourceBergen Drug Corp for Medroxyprogesterone 150 mg/mL, a progestin medication used in hormone replacement therapy and contraceptive applications. The contract, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries a firm fixed price and represents a non-competitive delivery order. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant standing as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. As a non-set-aside award, this delivery order reflects AmerisourceBergen's capability to meet federal procurement requirements in open competition. The company's extensive federal contract portfolio demonstrates its role in supplying essential medications across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ2UA?
SPE2DB25FQ2UA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FQ2UA worth?
The government has obligated $1,495 on SPE2DB25FQ2UA.
Is contract SPE2DB25FQ2UA an order under another contract?
Yes. SPE2DB25FQ2UA is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2UA competed?
The extent of competition for SPE2DB25FQ2UA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award